The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression

Nature Medicine

Volumn 3, Issue 10, 1997, Pages 1160-1162

  Michael, Nelson L ^a   Louie, Leslie G ^b   Rohrbaugh, Amy L ^c   Schultz, Kathleen A ^b   Dayhoff, Debora E ^c   Wang, Carol E ^c   Sheppard, Haynes W ^d  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^d CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DISEASE COURSE; DNA POLYMORPHISM; GENE DELETION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DNA PRIMERS; HIV-1; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RNA, VIRAL; SURVIVAL RATE; TIME FACTORS;

EID: 0030797831     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1097-1160     Document Type: Article

References (28)

1. Clapham, P.R., Blanc, D. & Weiss, R.A. Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by Simian immunodeficiency virus. Virology 181, 703-715 (1991).
2. Maddon, P.J. et al. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47, 333-348 (1986).
3. Clapham, P.R. & Weiss, R.A. Spoilt for choice of co-receptors. Nature 388, 230-231 (1997).
4. Choe, H. et al. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148 (1996).
5. Doranz, B.J. et al. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85, 1149-1158 (1996).
6. Rana, S. et al. Role of CCR5 in infection of primary macrophages and lymphocytes by M-tropic strains of HIV: Resistance to patient-derived and prototype isolates resulting from the ΔCCR5 mutation. J. Virol. 71, 3219-3227 (1997).
7. He, J. et al. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385, 645-649 (1997).
8. Martinson, J.J. et al. Global distribution of the CCR5 gene 32-base pair deletion. Nature Genet. 16, 100-103 (1997).
9. Liu, R. et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367-377 (1996).
10. Sampson, M. et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722-725 (1996).
11. Dean, M. et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273, 1856-1862 (1996).
12. Huang, Y. et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med. 2, 1240-1243 (1996).
13. Michael, N.L. et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nature Med. 3, 338-340 (1997).
14. Eugen-Olsen, J. et al. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS 11, 305-310 (1997).
15. Zimmerman, P.A. et al. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: Studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol. Med. 3, 23-36 (1997).
16. Biti, R. et al. HIV-1 infection in an individual homozygous for the CCR5 deletion allele [letter]. Nature Med. 3, 252-253 (1997).
17. O'Brien, T.R. et al. HIV-1 infection in a man homozygous for CCR5 delta 32 [letter]. Lancet 349, 1219 (1997).
18. Theodorou, I. et al. HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group [letter]. Lancet 349, 1219-1220 (1997).
19. Balotta, C. et al. Homozygous A32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. AIDS 11, F67-71 (1997).
20. Rappaport, J. et al. 32 bp CCR-5 gene deletion and resistance to fast progression in HIV-1 infected heterozygotes. Lancet 349, 922-923 (1997).
21. Smith, M.W. et al. Contrasting genetic influence of CCK2 and CCR5 variants on HIV-1 infection and disease progression. Science 277, 959-965 (1997).
22. Mellors, J.W. et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272, 1167-1170 (1996).
23. Wu, L. et al. CCR levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J. Exp. Med. 185, 1681-1691 (1997).
24. Frade, J.M.R. et al. The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection. J. Clin. Invest. 100, 497-502 (1997).
25. Winkelstein, W. Jr. et al. Sexual practices and risk of infection by the human immunodeficiency virus. The San Francisco Men's Health Study. JAMA 257, 321-325 (1987).
26. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb. Mortal. Wkly. Rep. 41, 1-19 (1992).
27. + T-cell levels. AIDS 7, 1159-1166 (1993).
28. Michael, N.L., Vahey, M., Burke, D.S. & Redfield, R.R. Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: Evidence for viral replication in all stages of HIV disease. J. Virol. 66, 310-316 (1992).